摘要
目的构建人IL-24基因真核表达载体,在CHO细胞中进行稳定表达,并检测重组表达蛋白rhIL-24的抗肿瘤活性。方法将测序验证的人IL-24基因亚克隆至真核表达载体pcDNA3,构建重组真核表达载体pcDNA3-hIL-24,转染CHO细胞进行稳定表达,经RT-PCR鉴定后用MTT法、Ho-echst染色和流式细胞术检测CHO细胞表达的rhIL-24诱导A549人肺腺癌细胞凋亡的抗肿瘤效应,用ELISA检测其刺激免疫细胞分泌IL-6和IFN-γ的功能。结果经双酶切和PCR鉴定,重组真核表达载体构建正确,人IL-24在CHO细胞中获得稳定表达,且所表达的人IL-24具有较强的诱导A549人肺腺癌细胞凋亡及上调免疫细胞表达IL-6和IFN-γ的免疫刺激活性。结论人IL-24基因的稳定表达和抗肿瘤效应的实验研究,为进一步研究人IL-24抗肿瘤的分子机制及潜在的应用奠定了基础。
Aim To construct the eukaryotic expression vector of hIL-24 cDNA , and express it in CHO cells and detect its anti-tumor effect of recombinant hIL-24 protein. Methods Constructed peDNA3-hIL-24 was identified by endonueleases digestion & PCR. The recombinant expression plasmids were transfeeted into CHO cells, human hIL-24 expressed in CHO cells was detected with RT-PCR. The apoptosis-indueing activities of recombinant protein hIL-24 was tested by MTr assay , Hoeehst& FCM assay, and the expression of IL- 6 and IFN-γ/from PBMC induced by rhIL-24 was tested by ELISA. Results The eukaryotie expression vector pcDNA3-hIL-24 was constructed correctly. Stable expression of human IL-24 in CHO cells was identified with RT-PCR. The apoptosis of A549 cells induced by hIL-24 was proved by Hoechst & FCM assay, and the expression of IL-6 and IFN-γ/from PBMC induced by rhIL-24 was identified with ELISA. Conclusion The successful stable expression & experimental study of apoptosis effect of human IL-24 gene lay the foundation for the further study of molecular mechanism of hIL-24 on anti-tumors and potential application.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2006年第5期567-570,共4页
Chinese Pharmacological Bulletin
基金
苏州大学医学发展基金资助项目(NoEE134517)